Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | |
| Sales | 30,575 | 26,178 |
| Cost of Goods | 15,833 | 13,547 |
| Gross Profit | 14,742 | 12,631 |
| Operating Expenses | 26,012 | 11,981 |
| Operating Income | -10,438 | 1,197 |
| Interest Expense | 37,801 | 30,373 |
| Other Income | -272 | -106 |
| Pre-tax Income | -48,510 | -29,282 |
| Income Tax | 1,359 | 138 |
| Net Income Continuous | -49,870 | -29,420 |
| Net Income | $-49,870 | $-29,420 |
| EPS Basic Total Ops | -62.50 | -52.80 |
| EPS Basic Continuous Ops | -62.30 | -52.54 |
| EPS Diluted Total Ops | -62.50 | -52.80 |
| EPS Diluted Continuous Ops | -62.30 | -52.54 |
| EBITDA(a) | $-8,947 | $2,454 |